OrbiMed raises $3 billion for its latest private equity vehicles, underscoring robust institutional demand for healthcare-focused investment strategies in both global and Asian regions.
OrbiMed successfully raised $3 billion for its global and Asian private equity funds, signaling strong investor demand for healthcare investments.
OrbiMed Advisors has successfully closed $3 billion in capital commitments for two new private equity funds. The firm continues to demonstrate strong investor appetite for specialized healthcare investments across global and Asian markets.
The capital is designated for two new private equity funds focused on global and Asian healthcare investments.